Future Investigators of Regenerative Medicine

  • White LinkedIn Icon
  • facebook
  • twitter

©2019 by Future Investigators of Regenerative Medicine

What is FIRM? 

The Future Investigators of Regenerative Medicine (FIRM) is a society established by Alex Lomas, Hareklea Markides, Jim Rose and David Smith of the EPSRC Doctoral Training Centre (DTC) in Regenerative Medicine based between Loughborough, Keele and Nottingham University. Recognising the ever growing regenerative medicine community we have decided to bring young researchers from European institutions and further afield together. With this, we give you; FIRM PhD Symposium.

This is a symposium organised by young researchers for young researchers. One of the main aims of the symposium is to encourage young researchers such as ourselves get to know each other on a friendly and informal level in this way establishing an international network from very early on in our careers. The FIRM Symposium will showcase the latest advances in regenerative medicine research undertaken Worldwide and create a platform on which to build collaboration.

Current Committee
 
IMG_1640_Original_edited.jpg
Niamh McCallum_edited.jpg
Domhnall-Kelly_edited.jpg
WhatsApp Image 2019-11-27 at 19.23_edite
Cathy B_edited.jpg

Katya Pchelintseva

Imperial College London

Background

After completing BSc in Biology with a final year dissertation on information theory-based gene regulatory networks, Katya graduated with an MSc in Biomedical Engineering from Imperial College London in 2016. Her masters thesis was focussed on developing a novel point-of-care device for HIV detection through supramolecular host-guest interactions.

 

Current work

She currently is completing a PhD in Materials in Imperial College London. Katya's research interests lie within acoustofluidics and superresolution microscopy, particularly in the context of cardiac tissue engineering. By applying these techniques, Katya aims to develop and characterise novel platforms for cardiac drug screening, which address the limitations of existing monolayer cultures. Katya is particularly fascinated by cell-material interactions and remote field effects on cardiomyocyte biology.  

 

Future interests

Katya is planning to pursue a career at the forefront of clinical translational research, developing solutions to global healthcare challenges. 

Niamh McCallum

University of Liverpool

 

Background

Niamh graduated with a Master’s of Chemistry degree in 2017 and, after spending some time working for pharmaceutical company Elanco, is now completing her PhD at the University of Liverpool.

 

Current work

Niamh’s PhD is focused on developing bimodal contrast agents for stem cell tracking with the purpose of gathering better safety and efficacy data surrounding cell therapies. Niamh is highly passionate about materials discovery and how such materials can be applied in a biomedical setting. As well as this, she has gained a lot of interest in the ethics and safety of regenerative medicine therapies over the course of her PhD.

 

Future interests

Niamh is keen to continue working with Nano biomaterials for medical applications.

Domhnall Kelly

Royal College of Surgeons in Ireland

 

Background

Domhnall is a Biochemistry graduate with an MSc in Regenerative Medicine and is completing his PhD in the field of Tissue Engineering at the Royal College of Surgeons in Ireland (RCSI).

 

Current work

Domhnall is a PhD researcher within the Tissue Engineering Research Group (TERG) at RCSI. His research focuses on the controlled delivery of scaffold-based therapeutics for the treatment of osteoarthritis and cartilage regeneration. He aims to develop a “gene-activated” platform capable of the controlled delivery of therapeutic siRNA using non-viral nanoparticle delivery vectors combined with a collagen-based scaffold which will function to reduce inflammatory responses during the regeneration of osteoarthritic cartilage.

Future interests

Domhnall hopes to continue researching the development of advanced drug delivery systems, with a particular interest on genetic therapies and their clinical translation. 

Lydia Beeken

University of Nottingham

 

Background

Lydia is a Biomedical Science graduate with an MRes in Translational Medicine, and is currently completing her PhD at the University of Nottingham.

 

Current work

She currently researches for her PhD in Academic Ophthalmology, where she investigates regenerative medicine strategies for ocular surface injuries. Her research involves exploring the therapeutic potential of corneal derived mesenchymal stem cells, and the development of a functionalised contact lens to behave as a scaffold for topical application of cells to the cornea.

Future interests

Lydia hopes to continue work within the field of cellular therapies, with an interest in clinical translation.

 

 

Cathy

Loughborough University

 

Background

Cathy is a Mechanical Engineering graduate with an MSc (Dist.) in Manufacturing Processes and Management. She is currently completing her PhD at Loughborough University.

 

Current work

She is currently conducting research in the Centre for Biological Engineering at
Loughborough University in collaboration with Advance Bioprocess and Hitachi Chemical.
Her research aims to reduce cost and increase quality in the manufacturing aspect of regenerative medicine by improving efficiency and controllability of its processes. To do so, she is exploring the use of mechanistic models that help to predict and then achieve desired outcomes.

Future interests

Cathy is interested in the industry side of regenerative medicine, particularly in process efficiency that allows the translation of scientific research to customer needs.

Please reload